The 2021 New Drug Approvals for Infectious Diseases: Deep Dive

The FDA in 2021 approved four novel small molecule drugs for various infectious diseases, including human immunodeficiency virus type-1 (HIV-1), post-transplant cytomegalovirus (CMV), vulvovaginal candidiasis, and human African trypanosomiasis (HAT; sleeping sickness). This article and slide deck explores each in more detail, including but not limited to their:

• target rationale

• disease context

• original patents

• key clinical data

• industry history